[go: up one dir, main page]

JPS6323965B2 - - Google Patents

Info

Publication number
JPS6323965B2
JPS6323965B2 JP8689879A JP8689879A JPS6323965B2 JP S6323965 B2 JPS6323965 B2 JP S6323965B2 JP 8689879 A JP8689879 A JP 8689879A JP 8689879 A JP8689879 A JP 8689879A JP S6323965 B2 JPS6323965 B2 JP S6323965B2
Authority
JP
Japan
Prior art keywords
coq
acid
drug
orally administered
fatty acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP8689879A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5612309A (en
Inventor
Satoshi Kobayashi
Hiroshi Furukawa
Kunitoshi Furuya
Akira Kondo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KH Neochem Co Ltd
Original Assignee
Kyowa Hakko Kogyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Hakko Kogyo Co Ltd filed Critical Kyowa Hakko Kogyo Co Ltd
Priority to JP8689879A priority Critical patent/JPS5612309A/ja
Publication of JPS5612309A publication Critical patent/JPS5612309A/ja
Publication of JPS6323965B2 publication Critical patent/JPS6323965B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
JP8689879A 1979-07-11 1979-07-11 Oral drug containing ubidecarenone Granted JPS5612309A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP8689879A JPS5612309A (en) 1979-07-11 1979-07-11 Oral drug containing ubidecarenone

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP8689879A JPS5612309A (en) 1979-07-11 1979-07-11 Oral drug containing ubidecarenone

Publications (2)

Publication Number Publication Date
JPS5612309A JPS5612309A (en) 1981-02-06
JPS6323965B2 true JPS6323965B2 (da) 1988-05-18

Family

ID=13899647

Family Applications (1)

Application Number Title Priority Date Filing Date
JP8689879A Granted JPS5612309A (en) 1979-07-11 1979-07-11 Oral drug containing ubidecarenone

Country Status (1)

Country Link
JP (1) JPS5612309A (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5618914A (en) * 1979-07-25 1981-02-23 Eisai Co Ltd Ubidecarenone composition having good absorbability
US5447729A (en) * 1994-04-07 1995-09-05 Pharmavene, Inc. Multilamellar drug delivery systems
JP2009515990A (ja) * 2005-11-17 2009-04-16 バイオアバイラビリティ，インク． 生体適合性潜在的乳化剤
EP3366280A1 (en) 2010-03-12 2018-08-29 Berg LLC Intravenous formulations of coenzyme q10 (coq10) and methods of use thereof

Also Published As

Publication number Publication date
JPS5612309A (en) 1981-02-06

Similar Documents

Publication Publication Date Title
EP0133110B1 (fr) Nouvelle composition pharmaceutique à base d'acide valproique et son procédé de fabrication
US20030229027A1 (en) Stabilized natural cannabinoid formulation
US4562069A (en) Two-phase formulation
WO1998007417A1 (fr) Compositions pharmaceutiques contenant de la coenzyme q¿10?
US5051406A (en) Pharmaceutical composition using albumin as a carrier and process for producing the same
FR2568472A1 (fr) Preparations pharmaceutiques retard et procede pour les fabriquer
JPH11509523A (ja) オメガ−３ポリ不飽和酸の経口投与剤を用いた炎症性腸疾患の治療方法
US5952383A (en) Pharmaceutical composition for oral delivery
CZ20014508A3 (cs) Protiplísňový orální prostředek obsahující itraconazol a způsob jeho přípravy
JP3285410B2 (ja) アントシアノシド類を含有する経口医薬組成物
JP2002529407A (ja) Ｌ−ｄｏｐａエチルエステル含有分散性組成物
Fernandes et al. Long-term treatment with fish oil prevents memory impairments but not hippocampal damage in rats subjected to transient, global cerebral ischemia
US4515804A (en) Crystal modifications of (+)-catechin and pharmaceutical preparations containing them
JP2005082594A (ja) 苦味を隠蔽する薬理組成物
JPS6323965B2 (da)
JP2005187405A (ja) 尿酸値抑制剤、及びプリン体吸着剤
Sosa et al. Topical antiinflammatory activity of an innovative aqueous formulation of actichelated® propolis vs two commercial propolis formulations
KR20010013365A (ko) 가용화된 세트랄린 조성물
JP2019023246A (ja) 有効成分の放出性が向上した医薬調製物における賦形剤としての炭酸水酸化マグネシウム
JPS63188623A (ja) 吸収改善ユビデカレノン製剤
JP3502951B2 (ja) 高脂血症治療剤
JPH01238526A (ja) ビタミンｅの吸収改善製剤
FR2649322A1 (fr) Complexes biodisponibles d'acide (alpha)-linolenique, extraits de plantes en contenant et compositions pharmaceutiques les incorporant
TWI361078B (en) Stabilized leukotriene b4 (ltb4) agent pharmaceutical formulation
Tembo et al. Impairment by cholestyramine of dicumarol and tromexan absorption in rats: a potential drug interaction